Effectiveness of influenza vaccine in reducing influenza-associated hospitalizations and deaths among the elderly population; Lazio region, Italy, season 2016-2017
- 10 April 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Expert Review of Vaccines
- Vol. 19 (5), 479-489
- https://doi.org/10.1080/14760584.2020.1750380
Abstract
Background: This study aimed to estimate influenza vaccine effectiveness (VE) in preventing influenza-related deaths and hospitalizations in the elderly population. Methods: We retrospectively analyzed the cohort of 1,251,218 elderly aged ≥65 years who were residing in the Lazio region in 2016-2017. We estimated influenza VE using the Cox proportional hazards model, adjusting for demographic characteristics, pre-existing health-risk conditions, and prior vaccinations. Results: Estimated VE was 14% (95% confidence interval (CI): 11 to 17); 26% (95%CI: 19 to 33) in preventing influenza-related deaths and 13% (95%CI: 10 to 16) in preventing influenza-related hospitalizations. Seasonal VE was higher in the elderly vaccinated in prior seasons (VE=20%, 95%CI: 17 to 23). We found no significant differences in effectiveness by vaccine type, although the MF59-adjuvanted vaccine appeared more effective than other vaccines in individuals aged ≥75 years, particularly in those aged ≥90 years (VE=18%, 95%CI: 9 to 26). Conclusions: Although VE was low, vaccination still provided benefits in preventing influenza-related hospitalizations and deaths in the elderly, particularly among those vaccinated in prior seasons. Efforts should therefore be made to improve vaccine uptake and the utilization of vaccines with greater effectiveness in the oldest elderly (e.g., high-dose and adjuvanted cell-based vaccines).Keywords
This publication has 33 references indexed in Scilit:
- Disease identification based on ambulatory drugs dispensation and in-hospital ICD-10 diagnoses: a comparisonBMC Health Services Research, 2013
- Stratified Estimates of Influenza Vaccine Effectiveness by Prior Vaccination: Caution RequiredClinical Infectious Diseases, 2013
- Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V®and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderlyHuman Vaccines & Immunotherapeutics, 2013
- Can we use the pharmacy data to estimate the prevalence of chronic conditions? a comparison of multiple data sourcesBMC Public Health, 2011
- Mortality benefits of influenza vaccination in elderly people: an ongoing controversyThe Lancet Infectious Diseases, 2007
- Assessing the burden of influenza and other respiratory infections in England and WalesJournal of Infection, 2007
- Immune remodeling: lessons from repertoire alterations during chronological aging and in immune-mediated diseaseTrends in Molecular Medicine, 2007
- Modelling hospital admissions for lower respiratory tract infections in the elderly in EnglandEpidemiology and Infection, 2006
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Value of Immunological Markers in Predicting Responsiveness to Influenza Vaccination in Elderly IndividualsJournal of Virology, 2001